Asia-Pacific Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Cancer, Others), Usage Pattern (Curative Care, Immunization, Other), Site Of Administration (Skin, Circulatory/Musculoskeletal System, Organs, Central Nervous System), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (Japan, China, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Market Analysis and Insights : Asia-Pacific Injectable Drug Delivery Market
Asia-Pacific injectable drug delivery market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 11.45% in the above mentioned forecast period and is expected to reach the USD 297.31 billion by 2029.
Formulations, technologies, procedures and systems for conveying a pharmaceutical ingredient in the body are collectively referred to as drug delivery. Needle-free injectors, pen injectors, auto injectors, and traditional syringes are among the injectable drug delivery systems.
One of the major factors likely to accelerate the growth and demand of the injectable drug delivery industry is the spike in sales for self-injection devices. Furthermore, the worldwide market is growing due to an increase in the incidence of chronic diseases such as diabetes and cancer. The growing need for drug delivery methods, rising healthcare expenditure and increase in research and development activities are the major factors influencing the market growth rate. The growing demand for injectables in treating large variety of disorders including Wilson's disease, autoimmune diseases, haemophilia, hepatitis C, and cystic fibrosis will further boost the market's growth.
Moreover, the high demand for biosimilar and generic injectable, quick scientific innovations and new product releases, and strong growth in the biologics industry will provide beneficial opportunities for the Injectable drug delivery market in the forecast period of 2022-2029.
However, the different infections connected with needle stick injuries and product recalls, are the factors that will hinder the market growth. The rise in demand for other forms of drug delivery will further challenge the Injectable drug delivery market in the forecast period mentioned above.
This Asia-Pacific injectable drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific injectable drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Injectable Drug Delivery Market Scope and Market Size
The Asia-Pacific injectable drug delivery market is segmented on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the injectable drug delivery market is segmented into injectable drug delivery devices and injectable drug delivery formulation. Injectable drug delivery devices have further been segmented into conventional injection devices and self-injection devices. Self-injection devices have further been sub-segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors and others. Injectable drug delivery formulation has further been segmented into conventional drug delivery formulation, novel drug delivery formulation and long-acting injection formulations. Novel drug delivery formulation has further been sub-segmented into colloidal dispersions and microparticles. Colloidal dispersions are further divided into niosomes, liposomes, polymeric/mixed micelles and nanoparticles. Micro particles are further divided into microspheres and microcapsules.
- On the basis of formulation packaging, the injectable drug delivery market is segmented into ampoules, vials, cartridges and bottles.
- Based on therapeutic application, the injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, orphan diseases, cancer and others.
- On the basis of usage pattern, the injectable drug delivery market is segmented into curative care, immunization and others.
- Based on site of administration, the injectable drug delivery market is segmented into skin, circulatory/musculoskeletal system, organs and central nervous system.
- On the basis of end-users, the injectable drug delivery market is segmented into clinic, hospital and others.
- The injectable drug delivery market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Asia-Pacific Injectable Drug Delivery Market Country Level Analysis
Asia-Pacific injectable drug delivery market is analyzed and market size information is provided by the country, type, formulation packaging, therapeutic application, usage pattern, site of administration, end-users and distribution channel as referenced above.
The countries covered in the Asia-Pacific injectable drug delivery market report are the Japan, China, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific.
China dominates the Asia-Pacific injectable drug delivery market due to the rising population, changing lifestyle and upsurge in the adoption rate of developed technologies.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Asia-Pacific injectable drug delivery market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Asia-Pacific Injectable Drug Delivery Market Share Analysis
Asia-Pacific injectable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Asia-Pacific injectable drug delivery market research.
Some of the major players operating in the Asia-Pacific injectable drug delivery market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter, BD, SCHOTT AG, Gerresheimer AG, Alkermes, Eli Lilly and Company, Sandoz, Terumo Corporation, Ypsomed AG and Bespak Europe Ltd., among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
